January 26th, 2026
Publication of Phase II Randomized Controlled Trial Results of BNCT for Recurrent High-Grade Meningioma in Neuro-Oncology, a journal of the Society for Neuro-Oncology
Stella Pharma Corporation announces that the results of the Phase II randomiz……
